Key result
Copper chloride demonstrated a dose-dependent antiviral effect against feline calicivirus in F81 cells with an IC50 of 5.1 μM, and showed a synergistic protective effect when combined with ribavirin.
Why the study?
Existing vaccines do not provide complete protection against feline calicivirus due to substantial genetic variability, prompting research into antiviral drugs.
Does copper chloride inhibit feline calicivirus in F81 cells?
Does copper chloride inhibit feline calicivirus in F81 cells?
Copper chloride demonstrates dose-dependent antiviral activity against feline calicivirus in vitro and acts synergistically with ribavirin.
Answers are grounded in this paper and cite their sources.
Copper chloride shows dose-dependent anti-FCV activity in vitro; leaves open clinical translation in cats.
Background: Feline calicivirus (FCV) is a common and highly prevalent pathogen causing upper respiratory diseases in kittens and felines in recent years. Due to the substantial genetic variability of the viral genes, existing vaccines cannot provide complete protection. Therefore, research on FCV antiviral drugs has received much attention. Results: In this study, we found that copper chloride had dose-dependent antiviral effects on FCV in F81 cells. We also found that the combination of copper chloride and ribavirin had a synergistic protective effect against FCV in F81 cells. In contrast, the combination of copper chloride and horse anti-FCV immunoglobulin F(ab') 2 showed an antagonistic effect, likely because copper chloride has an effect on F(ab') 2 immunoglobulin; however, further research is needed to clarify this supposition. Conclusions: In summary, we found that copper chloride had low cytotoxicity and significant antiviral effects on FCV in F81 cells, providing a new drug candidate for the prevention and treatment of FCV infection.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) studied Feline calicivirus infection. Copper chloride vs. Mock treatment (0.4% DMSO) was evaluated on Viral titer (TCID50) and relative RNA levels of FCV (IC50 5.1 μM, p=<0.001). Copper chloride demonstrated a dose-dependent antiviral effect against feline calicivirus in F81 cells with an IC50 of 5.1 μM, and showed a synergistic protective effect when combined with ribavirin.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: